Clinical Trials Logo
  1. Home
  2. Ocular Inflammation
  3. NCT00699153

Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery

Ocular Inflammation Clinical Trial

Official title:
Safety and Efficacy of Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery

Clinical Trial Summary

Evaluation of the clinical safety and efficacy of loteprednol etabonate in an ophthalmic base, when compared to vehicle for the treatment of inflammation following cataract surgery.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00699153
Study type Interventional
Source Bausch & Lomb Incorporated
Contact
Status Completed
Phase Phase 3
Start date June 2008
Completion date June 2009
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05618730 - Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B Phase 1
Not yet recruiting NCT05248139 - Safety and Effectiveness of Drop-free Small Incision Cataract Surgery N/A
Terminated NCT01214174 - Efficacy and Safety Study of IBI-10090 in Cataract Surgery Patients Phase 2
Completed NCT03332342 - Closed Eye Neutrophils in Dry Eye Disease N/A
Completed NCT02128113 - RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD Phase 2
Completed NCT01808547 - Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects Phase 3
Completed NCT04374656 - Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic
Recruiting NCT05668455 - Comparison of Topical Treatment for Inflammatory Secretions of the Conjonctiva (Patients With Ocular Prostheses) Phase 3
Completed NCT00645671 - Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery Phase 3
Completed NCT00789971 - Triamcinolone Versus Topical Treatment in Post Operative Phacoemulsification N/A
Completed NCT02786901 - LE Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery Phase 3
Terminated NCT03596723 - KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children Phase 3
Completed NCT01576952 - Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects Phase 3
Withdrawn NCT03408015 - Effects of Xiidra on Closed Eye Tear Film Leukocytes in Dry Eye Disease Phase 4
Completed NCT03580473 - Efficacy and Safety of Saturno IIB Association on the Control of Ocular Inflammation Post-phacoemulsification Phase 2
Completed NCT04812951 - Cyclosporine 0.1% Eye Drops as Prophylactic Treatment In Cataract Surgery Early Phase 1
Completed NCT03302273 - Corneal Epithelial Stem Cells and Dry Eye Disease N/A
Completed NCT04690829 - Biomarkers in Ocular Inflammation and Uveitis
Withdrawn NCT01721694 - Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection Phase 3
Completed NCT03521791 - Efficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pterygium vs Placebo. Phase 4